NCT06340386

Brief Summary

This is a validation study of the italian language for the Female Sexual Function Index-Breast Cancer questionnaire. The validation of the instrument in Italian will allow the identification of possible issues related to sexual health and enable the provision of adequate medical and psychosexual counseling to these patients, both in clinical practice and in research studies.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
600

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2020

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 19, 2020

Completed
3.4 years until next milestone

First Submitted

Initial submission to the registry

March 26, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 1, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

April 1, 2024

Status Verified

March 1, 2024

Enrollment Period

4.2 years

First QC Date

March 26, 2024

Last Update Submit

March 26, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Validation of the italian translation of Female Sexual Function Index-Breast Cancer questionnaire

    The measure of internal consistency utilized is Cronbach's alpha (α). The comparison will be done between the estimated α in the Italian questionnaire and the α of the original work.

    12 months

Study Arms (2)

Patients with breast cancer and age <=50 years

Patients with diagnosis of breast cancer and age \<=50 years

Patients with breast cancer and age >50 years

Patients with diagnosis of breast cancer and age \>50 years

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients treated at European Institute of Oncology for a operable breast cancer between 2012 and 2020

You may qualify if:

  • Women with operable breast cancer;
  • Operated on between 2012 and 2020;
  • Randomly selected from the institutional database; 18 years of age (Age stratification: equally represented women aged \<50 years and women aged ≥50 years);
  • Signing of the informed consent.

You may not qualify if:

  • Severe psychiatric or cognitive illness;
  • Ongoing psychological treatment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

European Institute of Oncology

Milan, Italy

RECRUITING

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Gabriella Pravettoni

    European Institute of Oncology

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Gabriella Pravettoni

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 26, 2024

First Posted

April 1, 2024

Study Start

October 19, 2020

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

April 1, 2024

Record last verified: 2024-03

Locations